세계의 동물 표준 실험실 시장 : 서비스별, 용도별, 동물 유형별, 최종 사용자별, 지역별, 예측(-2030년)

The veterinary reference laboratory market is forecasted to grow from USD 4.75 million in 2025 to USD 6.46 million by 2030, recording a CAGR of 6.3%. The increasing prevalence of zoonotic and chronic animal diseases, rising companion animal ownership, and the growing emphasis on preventive healthcare primarily drive market expansion.

The rising demand for advanced diagnostic testing, including molecular diagnostics, immunodiagnostics, and clinical chemistry, has accelerated the establishment of high-throughput reference laboratories in both developed and emerging regions. Moreover, technological advancements in automation, AI-based image analysis, and molecular testing are enabling faster turnaround times and improved diagnostic accuracy, fostering greater trust among veterinarians and pet owners.

At the same time, the increasing integration of diagnostic services with digital platforms and laboratory information management systems (LIMS) is streamlining workflows, enhancing sample traceability, and enabling remote access to test results. The rising focus on early disease detection and companion animal wellness programs further supports test adoption, while expanding veterinary corporatization and partnerships between clinics and reference labs are driving consistent sample inflows. However, the market faces challenges such as high operational and testing costs, a shortage of skilled laboratory professionals, and stringent regulatory standards governing veterinary diagnostics. Additionally, maintaining quality assurance across diverse geographies and addressing biosecurity and sample transport challenges remain key priorities for laboratories aiming to sustain accuracy, reliability, and growth momentum.

The clinical pathology segment accounted for the largest share of the market, by application, in 2024.

Based on application, the veterinary reference laboratory market is segmented into clinical pathology, bacteriology, virology, parasitology, and other applications. In 2024, clinical pathology accounted for the largest share of the market. This dominance is attributed to the segment's critical role in delivering detailed diagnostic insights through hematology, cytology, and clinical chemistry testing. These analyses enable veterinarians to accurately diagnose systemic disorders, track therapeutic progress, and effectively manage complex disease conditions. The rising companion animal population and increasing frequency of veterinary consultations have fueled the demand for routine pathology services. Moreover, technological advancements in automated analyzers and digital pathology systems have significantly improved diagnostic precision, efficiency, and turnaround time, further driving market growth in this segment.

The veterinary clinics & hospitals segment is expected to dominate the market, by end user, during the forecast period.

Based on end user, the veterinary reference laboratory market is segmented into veterinary clinics and hospitals, research institutes and universities, point-of-care/in-house labs, and other end users. In 2024, veterinary clinics and hospitals accounted for the largest share of the global market. This dominance is primarily driven by the rising volume of diagnostic testing conducted through referral partnerships with centralized laboratories, as clinics increasingly outsource advanced and specialized tests such as molecular diagnostics, immunodiagnostics, and clinical chemistry to improve diagnostic accuracy and efficiency.

The growing companion animal population, higher pet healthcare expenditure, and expanding network of small and large veterinary practices have further contributed to the rising sample inflow from clinics and hospitals. These facilities rely on reference laboratories for confirmatory and complex testing that cannot be efficiently performed in-house, thereby enhancing treatment outcomes and operational workflows. Additionally, the integration of digital sample management systems and automated result reporting between clinics and reference labs is improving turnaround times and supporting evidence-based veterinary care.

In 2024, North America dominated the veterinary reference laboratory market.

The veterinary reference laboratory market is segmented into North America, Europe, Asia Pacific, and the Middle East & Africa. In 2024, North America accounted for the largest share of the global market. This dominance can be attributed to several key factors, including the high prevalence of companion animal ownership, strong awareness of preventive veterinary care, and significant healthcare expenditure on pets across the region. The presence of leading industry players such as IDEXX Laboratories, Zoetis Services LLC, and Mars, Incorporated, coupled with a well-established network of veterinary hospitals and diagnostic centers, has further reinforced the region's leadership. Within North America, the United States held the largest market share, supported by the country's advanced veterinary infrastructure, growing demand for specialized and molecular diagnostic testing, and rapid adoption of automation and digital pathology solutions. Additionally, the U.S. market benefits from favorable pet insurance penetration, a robust ecosystem of veterinary service providers, and strong investment in R&D for companion and livestock diagnostic innovations.

Breakdown of supply-side primary interviews:

• By Company Type: Tier 1 (45%), Tier 2 (20%), and Tier 3 (35%)
• By Designation: C-level Executives (35%), Directors (25%), and Other Designations (40%)
• By Region: North America (40%), Europe (25%), Asia Pacific (20%), Latin America (10%), and Middle East & Africa (5%)

Breakdown of demand-side primary interviews:

• By Company Type: Veterinary Clinics & Hospitals (70%), POC/In-house labs (15%), Research Institutions and Universities (10%), and Other End Users (5%)
• By Designation: Veterinary Healthcare Professionals (35%), Department Heads (27%), Procurement Heads (22%), and Other Designations (16%)
• By Region: North America (40%), Europe (25%), Asia Pacific (20%), Latin America (10%), and Middle East & Africa (5%)

Research Coverage

This report studies the veterinary reference laboratory market based on service, application, animal type, end user, and region. It also studies factors affecting market growth (drivers, restraints, opportunities, and challenges). It analyzes the market's opportunities and challenges and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to six main regions and respective countries.

Reasons to Buy the Report

The report can help established companies and new or smaller firms understand market trends, which will help them capture a larger market share. Firms that purchase the report can utilize one or more of the five strategies mentioned below.

This report provides insights into the following points:

• Analysis of key drivers, opportunities, restraints, and challenges influencing the growth of the veterinary reference laboratory market.
• Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and service launches in the veterinary reference laboratory market
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various types of veterinary reference laboratory services across regions.
• Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the veterinary reference laboratory market.
• Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the veterinary reference laboratory market.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 MARKET SEGMENTATION
  • 1.3.2 REGIONAL SCOPE
  • 1.3.3 INCLUSIONS & EXCLUSIONS
  • 1.3.4 YEARS CONSIDERED
• 1.4 MARKET STAKEHOLDERS
• 1.5 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
• 2.2 RESEARCH METHODOLOGY DESIGN
  • 2.2.1 SECONDARY DATA
    • 2.2.1.1 Key sources of secondary research
    • 2.2.1.2 Key objectives of secondary research
    • 2.2.1.3 Key data from secondary sources
  • 2.2.2 PRIMARY DATA
    • 2.2.2.1 Key primary sources
    • 2.2.2.2 Key objectives of primary research
    • 2.2.2.3 Key data from primary sources
    • 2.2.2.4 Key industry insights
• 2.3 MARKET SIZE ESTIMATION
  • 2.3.1 REVENUE SHARE ANALYSIS
  • 2.3.2 COMPANY PRESENTATIONS AND PRIMARY INTERVIEWS
  • 2.3.3 DEMAND-SIDE ANALYSIS
  • 2.3.4 TOP-DOWN APPROACH
  • 2.3.5 BOTTOM-UP APPROACH
• 2.4 DATA TRIANGULATION
• 2.5 MARKET SHARE ANALYSIS
• 2.6 STUDY ASSUMPTIONS
  • 2.6.1 MARKET ASSUMPTIONS
  • 2.6.2 GROWTH RATE ASSUMPTIONS
• 2.7 RISK ANALYSIS
• 2.8 RESEARCH LIMITATIONS
  • 2.8.1 METHODOLOGY-RELATED LIMITATIONS
  • 2.8.2 SCOPE-RELATED LIMITATIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 VETERINARY REFERENCE LABORATORY MARKET OVERVIEW
• 4.2 ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET, BY PRODUCT AND COUNTRY (2024)
• 4.3 VETERINARY REFERENCE LABORATORY MARKET: REGIONAL MIX
• 4.4 VETERINARY REFERENCE LABORATORY MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
• 4.5 VETERINARY REFERENCE LABORATORY MARKET: DEVELOPED VS. EMERGING ECONOMIES

5 MARKET OVERVIEW

• 5.1 MARKET DYNAMICS
  • 5.1.1 DRIVERS
    • 5.1.1.1 Growing routine wellness and oncology screening in companion animals
    • 5.1.1.2 Rapid adoption of digital pathology and telepathology
    • 5.1.1.3 Increasing prevalence/awareness of zoonotic and emerging diseases
    • 5.1.1.4 Growth in companion animal population
    • 5.1.1.5 Rising demand for animal-derived food products
    • 5.1.1.6 Increasing demand for pet insurance and growing animal health expenditure
  • 5.1.2 RESTRAINTS
    • 5.1.2.1 Competition from in-clinic and point-of-care testing
    • 5.1.2.2 High capital investment and fixed cost burden in veterinary reference laboratories
  • 5.1.3 OPPORTUNITIES
    • 5.1.3.1 Potential growth opportunities in emerging economies
    • 5.1.3.2 Investment in advanced technologies in veterinary reference laboratories
  • 5.1.4 CHALLENGES
    • 5.1.4.1 Competitive pressure and margin pressure in veterinary reference laboratories
    • 5.1.4.2 Data privacy, biosecurity, and sample ownership in veterinary reference laboratories
• 5.2 INDUSTRY TRENDS
  • 5.2.1 DIGITAL PATHOLOGY, TELECYTOLOGY, AND AI FROM PILOT TO COMMERCIAL SERVICES
  • 5.2.2 CONTINUED CONSOLIDATION AND VERTICAL INTEGRATION ACROSS ANIMAL-HEALTH ECOSYSTEM
• 5.3 TECHNOLOGY ANALYSIS
  • 5.3.1 KEY TECHNOLOGIES
    • 5.3.1.1 Real-time PCR/Quantitative PCR (qPCR) and digital PCR (dPCR)
    • 5.3.1.2 Next-generation/Metagenomic sequencing (NGS/mNGS)
    • 5.3.1.3 CRISPR-based diagnostics
  • 5.3.2 ADJACENT TECHNOLOGIES
    • 5.3.2.1 Integrated LIMS and one health surveillance platforms
    • 5.3.2.2 AI-driven diagnostic tools
  • 5.3.3 COMPLEMENTARY TECHNOLOGIES
    • 5.3.3.1 Telepathology
    • 5.3.3.2 Breath and saliva-based diagnostic tools
• 5.4 PORTER'S FIVE FORCES ANALYSIS
  • 5.4.1 THREAT OF NEW ENTRANTS
  • 5.4.2 THREAT OF SUBSTITUTES
  • 5.4.3 BARGAINING POWER OF SUPPLIERS
  • 5.4.4 BARGAINING POWER OF BUYERS
  • 5.4.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.5 KEY STAKEHOLDERS & BUYING CRITERIA
  • 5.5.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.5.2 KEY BUYING CRITERIA
• 5.6 REGULATORY ANALYSIS
  • 5.6.1 REGULATORY LANDSCAPE
    • 5.6.1.1 North America
      • 5.6.1.1.1 US
    • 5.6.1.2 Europe
  • 5.6.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• 5.7 PATENT ANALYSIS
  • 5.7.1 PATENT PUBLICATION TRENDS FOR VETERINARY REFERENCE LABORATORY
  • 5.7.2 JURISDICTION & TOP APPLICANT ANALYSIS
  • 5.7.3 MAJOR PATENTS
• 5.8 PRICING ANALYSIS
  • 5.8.1 AVERAGE SELLING PRICE TREND OF VETERINARY REFERENCE LABORATORY SERVICES, BY KEY PLAYER, 2022-2024
  • 5.8.2 AVERAGE SELLING PRICE TREND OF CLINICAL CHEMISTRY AND IMMUNODIAGNOSTIC SERVICES, BY REGION, 2022-2024
• 5.9 REIMBURSEMENT ANALYSIS
• 5.10 PET PARENT BEHAVIOUR
• 5.11 KEY CONFERENCES & EVENTS, 2025-2026
• 5.12 END-USER PERSPECTIVE & UNMET NEEDS
• 5.13 IMPACT OF AI/GEN AI ON VETERINARY REFERENCE LABORATORY MARKET
  • 5.13.1 INTRODUCTION
  • 5.13.2 MARKET POTENTIAL IN VETERINARY REFERENCE LABORATORY ECOSYSTEM
  • 5.13.3 AI-USE CASES
  • 5.13.4 KEY COMPANIES IMPLEMENTING AI
• 5.14 ECOSYSTEM MAP
• 5.15 ROLE IN ECOSYSTEM
• 5.16 VALUE CHAIN ANALYSIS
• 5.17 INVESTMENT & FUNDING SCENARIO
• 5.18 CASE STUDY ANALYSIS
  • 5.18.1 DIGITAL CYTOLOGY WORKFLOW ACCELERATION TO ENHANCE DIAGNOSTIC TURNAROUND IN VETERINARY PRACTICES
  • 5.18.2 IDEXX-CANCERDX (LYMPHOMA DIAGNOSTIC SERVICE) TO ADVANCE ONCOLOGY DETECTION THROUGH BLOOD-BASED TESTING
  • 5.18.3 VIRTUAL LABORATORY INTEGRATION TO ENHANCE CYTOLOGY TURNAROUND AND CLINICAL WORKFLOW
• 5.19 TRENDS/DISRUPTIONS IMPACTING CUSTOMER'S BUSINESS
• 5.20 IMPACT OF 2025 US TARIFF ON VETERINARY REFERENCE LABORATORY MARKET
  • 5.20.1 INTRODUCTION
  • 5.20.2 KEY TARIFF RATES
  • 5.20.3 PRICE IMPACT ANALYSIS
  • 5.20.4 IMPACT ON COUNTRY/REGION
    • 5.20.4.1 North America
    • 5.20.4.2 Europe
    • 5.20.4.3 Asia Pacific
    • 5.20.4.4 Latin America
  • 5.20.5 IMPACT ON END-USE INDUSTRIES
    • 5.20.5.1 Veterinary hospitals & clinics
    • 5.20.5.2 Point-of-care (POC) and in-house testing setups
    • 5.20.5.3 Veterinary research institutes & universities
    • 5.20.5.4 Other end users

6 VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE

• 6.1 INTRODUCTION
• 6.2 CLINICAL CHEMISTRY
  • 6.2.1 VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE
    • 6.2.1.1 Companion animals
      • 6.2.1.1.1 Rising pet ownership and preventive health trends to drive segment growth
    • 6.2.1.2 Livestock animals
      • 6.2.1.2.1 Rising focus on herd health, food safety, and export compliance to strengthen segment growth
• 6.3 IMMUNODIAGNOSTICS
  • 6.3.1 VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE
    • 6.3.1.1 ELISA
      • 6.3.1.1.1 ELISA tests to dominate immunodiagnostics segment owing to widespread use in infectious disease detection
  • 6.3.2 LATERAL FLOW ASSAYS
    • 6.3.2.1 Technological advancements and cost-effectiveness to aid market growth
  • 6.3.3 ALLERGEN-SPECIFIC IMMUNODIAGNOSTIC TESTS
    • 6.3.3.1 Rising prevalence of atopic disorders and adoption of precision allergy testing to augment market growth
  • 6.3.4 OTHER IMMUNODIAGNOSTIC SERVICES
  • 6.3.5 VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE
    • 6.3.5.1 Companion animals
      • 6.3.5.1.1 High pet care spending and preventive diagnostics to propel market growth
    • 6.3.5.2 Livestock animals
      • 6.3.5.2.1 Regulatory compliance, food safety, and disease surveillance to sustain steady demand
• 6.4 MOLECULAR DIAGNOSTICS
  • 6.4.1 VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE
  • 6.4.2 PCR TESTS
    • 6.4.2.1 High sensitivity and diagnostic accuracy to drive dominance of PCR tests
  • 6.4.3 MICROARRAYS
    • 6.4.3.1 Advancements in genetic profiling and pharmacogenomics to expand microarray applications
  • 6.4.4 NUCLEIC ACID SEQUENCING
    • 6.4.4.1 Rising adoption of next-generation sequencing and precision genomics to fuel market growth
  • 6.4.5 OTHER MOLECULAR DIAGNOSTIC SERVICES
  • 6.4.6 VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE
    • 6.4.6.1 Companion animals
      • 6.4.6.1.1 High pet-owner spending, precision diagnostics, and rapid turnaround to drive dominance
    • 6.4.6.2 Livestock animals
      • 6.4.6.2.1 Regulatory mandates, disease surveillance, and one health initiatives to strengthen market presence
• 6.5 HEMATOLOGY
  • 6.5.1 VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE
    • 6.5.1.1 Companion animals
      • 6.5.1.1.1 High diagnostic frequency and technological advancements TO sustain segment growth
    • 6.5.1.2 Livestock animals
      • 6.5.1.2.1 Rising focus on herd health, biosecurity, and productivity optimization to drive steady market growth
• 6.6 URINALYSIS
  • 6.6.1 VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE
    • 6.6.1.1 Companion animals
      • 6.6.1.1.1 Rising incidences of renal diseases in companion animals to drive market
    • 6.6.1.2 Livestock animals
      • 6.6.1.2.1 Growing emphasis on metabolic profiling and precision herd management to strengthen livestock urinalysis segment
• 6.7 HISTOPATHOLOGY & CYTOLOGY
  • 6.7.1 VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE
    • 6.7.1.1 Companion animals
      • 6.7.1.1.1 Clinical reliance on laboratory-based tissue and cellular diagnostics for definitive case management to drive market
    • 6.7.1.2 Livestock animals
      • 6.7.1.2.1 Biosecurity investments and disease surveillance programs to drive steady demand
• 6.8 MICROBIOLOGY
  • 6.8.1 VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE
    • 6.8.1.1 Companion animals
      • 6.8.1.1.1 Rising AMR awareness and shift toward rapid and automated testing to spur market growth
    • 6.8.1.2 Livestock animals
      • 6.8.1.2.1 Antimicrobial resistance monitoring and food safety compliance to sustain demand
• 6.9 OTHER SERVICES
  • 6.9.1 VETERINARY REFERENCE LABORATORY MARKET FOR OTHER SERVICES, BY ANIMAL TYPE
    • 6.9.1.1 Companion animals
    • 6.9.1.2 Livestock animals

7 VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION

• 7.1 INTRODUCTION
• 7.2 CLINICAL PATHOLOGY
  • 7.2.1 INCREASING AWARENESS OF ANIMAL HEALTH TO DRIVE MARKET
• 7.3 BACTERIOLOGY
  • 7.3.1 GROWTH IN VETERINARY HEALTHCARE EXPENDITURE TO DRIVE MARKET
• 7.4 VIROLOGY
  • 7.4.1 EMERGING INFECTIOUS DISEASES IN ANIMALS TO PROPEL MARKET GROWTH
• 7.5 PARASITOLOGY
  • 7.5.1 RISING PREVALENCE OF ZOONOTIC DISEASES TO AUGMENT MARKET GROWTH
• 7.6 PRODUCTIVITY TESTING
  • 7.6.1 EXPANSION OF LIVESTOCK INDUSTRIES TO SUPPORT MARKET GROWTH
• 7.7 PREGNANCY TESTING
  • 7.7.1 ADVANCED BREEDING TECHNIQUES AND RESPONSIBLE PET OWNERSHIP TO DRIVE MARKET GROWTH
• 7.8 TOXICOLOGY TESTING
  • 7.8.1 GLOBALIZATION OF FOOD SUPPLY CHAINS TO PROPEL MARKET GROWTH
• 7.9 OTHER APPLICATIONS

8 VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE

• 8.1 INTRODUCTION
• 8.2 COMPANION ANIMALS
  • 8.2.1 DOGS
    • 8.2.1.1 High insurance coverage and availability of reimbursements to drive market
  • 8.2.2 CATS
    • 8.2.2.1 Increasing pet cat population to support market uptake
  • 8.2.3 HORSES
    • 8.2.3.1 Growing awareness regarding equine health to fuel market growth
  • 8.2.4 OTHER COMPANION ANIMALS
• 8.3 LIVESTOCK ANIMALS
  • 8.3.1 CATTLE
    • 8.3.1.1 Growing consumption of dairy products to drive market growth
  • 8.3.2 SWINE
    • 8.3.2.1 Increasing incidence of infectious diseases to fuel market growth
  • 8.3.3 POULTRY
    • 8.3.3.1 Increasing demand for poultry meat to spur market growth
  • 8.3.4 SHEEP & GOATS
    • 8.3.4.1 International trade and strict health regulations to drive market
  • 8.3.5 OTHER LIVESTOCK ANIMALS

9 VETERINARY REFERENCE LABORATORY MARKET, BY END USER

• 9.1 INTRODUCTION
• 9.2 VETERINARY HOSPITALS & CLINICS
  • 9.2.1 RISING PET OWNERSHIP AND GROWING DIAGNOSTIC AWARENESS TO DRIVE DEMAND FOR VETERINARY REFERENCE LABS
• 9.3 POINT-OF-CARE/IN-HOUSE TESTING
  • 9.3.1 INCREASING COLLABORATIONS BETWEEN IN-HOUSE DIAGNOSTIC SETUPS AND REFERENCE LABORATORIES TO AID MARKET GROWTH
• 9.4 VETERINARY RESEARCH INSTITUTES & UNIVERSITIES
  • 9.4.1 INCREASING ACADEMIC COLLABORATIONS AND FUNDING TO DRIVE UTILIZATION OF REFERENCE LABORATORY SERVICES
• 9.5 OTHER END USERS

10 VETERINARY REFERENCE LABORATORY MARKET, BY REGION

• 10.1 INTRODUCTION
• 10.2 NORTH AMERICA
  • 10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 10.2.2 US
    • 10.2.2.1 US to dominate Norths American veterinary reference laboratory market during forecast period
  • 10.2.3 CANADA
    • 10.2.3.1 Growing pet adoption, rising animal healthcare expenditure, and increasing number of veterinary practices to drive market
• 10.3 EUROPE
  • 10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 10.3.2 GERMANY
    • 10.3.2.1 Increasing pet healthcare expenditure and rising demand for animal-derived food products to aid market growth
  • 10.3.3 UK
    • 10.3.3.1 Increased pet ownership and availability of animal health insurance policies to augment market growth
  • 10.3.4 FRANCE
    • 10.3.4.1 Growth of livestock industry and high companion animal population to support market growth
  • 10.3.5 ITALY
    • 10.3.5.1 Rising awareness about pet healthcare to drive market
  • 10.3.6 SPAIN
    • 10.3.6.1 Growing demand for pig and poultry products to drive market
  • 10.3.7 NETHERLANDS
    • 10.3.7.1 Increasing animal healthcare expenditure to drive market growth
  • 10.3.8 REST OF EUROPE
• 10.4 ASIA PACIFIC
  • 10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 10.4.2 CHINA
    • 10.4.2.1 Large pool of food-producing animals to drive market
  • 10.4.3 JAPAN
    • 10.4.3.1 Awareness about zoonotic diseases and increased pet expenditure to propel market growth
  • 10.4.4 INDIA
    • 10.4.4.1 Growing demand for livestock products and increasing awareness about animal health to support market growth
  • 10.4.5 AUSTRALIA
    • 10.4.5.1 Increasing investments in pet services and products to aid market growth
  • 10.4.6 SOUTH KOREA
    • 10.4.6.1 Increasing pet population in urban households to drive market
  • 10.4.7 THAILAND
    • 10.4.7.1 Rapidly expanding companion animal population to create higher demand for advanced diagnostic testing
  • 10.4.8 NEW ZEALAND
    • 10.4.8.1 Increased demand for preventive care and high aging pet population to drive market growth
  • 10.4.9 REST OF ASIA PACIFIC
• 10.5 LATIN AMERICA
  • 10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 10.5.2 BRAZIL
    • 10.5.2.1 Increasing use of reproductive technologies in livestock industry to propel market growth
  • 10.5.3 MEXICO
    • 10.5.3.1 Increasing adoption of advanced diagnostic technologies to propel market growth
  • 10.5.4 ARGENTINA
    • 10.5.4.1 Focus on advanced healthcare and regular disease monitoring among companion animals to drive market
  • 10.5.5 REST OF LATIN AMERICA
• 10.6 MIDDLE EAST & AFRICA
  • 10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
  • 10.6.2 GCC COUNTRIES
    • 10.6.2.1 Kingdom of Saudi Arabia
      • 10.6.2.1.1 Technology advancements in veterinary diagnostics to boost market growth
    • 10.6.2.2 UAE
      • 10.6.2.2.1 Government support and favorable initiatives to fuel market growth
    • 10.6.2.3 Rest of GCC Countries
  • 10.6.3 REST OF MIDDLE EAST & AFRICA

11 COMPETITIVE LANDSCAPE

• 11.1 INTRODUCTION
• 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • 11.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN VETERINARY REFERENCE LABORATORY MARKET
• 11.3 REVENUE ANALYSIS, 2020-2024
• 11.4 MARKET SHARE ANALYSIS, 2024
  • 11.4.1 RANKING OF KEY MARKET PLAYERS
  • 11.4.2 GLOBAL MARKET SHARE ANALYSIS
  • 11.4.3 US MARKET SHARE ANALYSIS
• 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
  • 11.5.1 STARS
  • 11.5.2 EMERGING LEADERS
  • 11.5.3 PERVASIVE PLAYERS
  • 11.5.4 PARTICIPANTS
  • 11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
    • 11.5.5.1 Company footprint
    • 11.5.5.2 Region footprint
    • 11.5.5.3 Service footprint
    • 11.5.5.4 Animal type footprint
• 11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
  • 11.6.1 PROGRESSIVE COMPANIES
  • 11.6.2 RESPONSIVE COMPANIES
  • 11.6.3 DYNAMIC COMPANIES
  • 11.6.4 STARTING BLOCKS
  • 11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SME PLAYERS, 2024
    • 11.6.5.1 Detailed list of key startups/SME players
    • 11.6.5.2 Competitive benchmarking of key emerging players/startups
• 11.7 BRAND/PRODUCT COMPARISON
• 11.8 R&D EXPENDITURE OF KEY PLAYERS
• 11.9 COMPANY VALUATION & FINANCIAL METRICS
  • 11.9.1 FINANCIAL METRICS
  • 11.9.2 COMPANY VALUATION
• 11.10 COMPETITIVE SCENARIO
  • 11.10.1 SERVICE LAUNCHES & ENHANCEMENTS
  • 11.10.2 DEALS
  • 11.10.3 EXPANSIONS
  • 11.10.4 OTHER DEVELOPMENTS

12 COMPANY PROFILES

• 12.1 KEY PLAYERS
  • 12.1.1 IDEXX LABORATORIES, INC.
    • 12.1.1.1 Business overview
    • 12.1.1.2 Services offered
    • 12.1.1.3 Recent developments
      • 12.1.1.3.1 Service launches and enhancements
    • 12.1.1.4 MnM view
      • 12.1.1.4.1 Key strengths
      • 12.1.1.4.2 Strategic choices
      • 12.1.1.4.3 Weaknesses & competitive threats
  • 12.1.2 MARS, INCORPORATED
    • 12.1.2.1 Business overview
    • 12.1.2.2 Services offered
    • 12.1.2.3 Recent developments
      • 12.1.2.3.1 Service launches
      • 12.1.2.3.2 Deals
      • 12.1.2.3.3 Expansions
    • 12.1.2.4 MnM view
      • 12.1.2.4.1 Key strengths
      • 12.1.2.4.2 Strategic choices
      • 12.1.2.4.3 Weaknesses & competitive threats
  • 12.1.3 ZOETIS SERVICES LLC
    • 12.1.3.1 Business overview
    • 12.1.3.2 Services offered
    • 12.1.3.3 Recent developments
      • 12.1.3.3.1 Deals
      • 12.1.3.3.2 Expansions
    • 12.1.3.4 MnM view
      • 12.1.3.4.1 Key strengths
      • 12.1.3.4.2 Strategic choices
      • 12.1.3.4.3 Weaknesses & competitive threats
  • 12.1.4 GD (ROYAL GD ANIMAL HEALTH)
    • 12.1.4.1 Business overview
    • 12.1.4.2 Services offered
    • 12.1.4.3 Recent developments
      • 12.1.4.3.1 Service launches
      • 12.1.4.3.2 Deals
      • 12.1.4.3.3 Expansions
    • 12.1.4.4 MnM view
      • 12.1.4.4.1 Key strengths
      • 12.1.4.4.2 Strategic choices
      • 12.1.4.4.3 Weaknesses & competitive threats
  • 12.1.5 LABOKLIN GMBH & CO. KG
    • 12.1.5.1 Business overview
    • 12.1.5.2 Services offered
    • 12.1.5.3 Recent developments
      • 12.1.5.3.1 Service launches
    • 12.1.5.4 MnM view
      • 12.1.5.4.1 Key strengths
      • 12.1.5.4.2 Strategic choices
      • 12.1.5.4.3 Weaknesses & competitive threats
  • 12.1.6 CVS (UK) LIMITED
    • 12.1.6.1 Business overview
    • 12.1.6.2 Services offered
    • 12.1.6.3 Recent developments
      • 12.1.6.3.1 Service launches
  • 12.1.7 NATIONAL VETERINARY SERVICES LABORATORY USDA-APHIS
    • 12.1.7.1 Business overview
    • 12.1.7.2 Services offered
  • 12.1.8 ANIMAL AND PLANT HEALTH AGENCY
    • 12.1.8.1 Business overview
    • 12.1.8.2 Services offered
    • 12.1.8.3 Recent developments
      • 12.1.8.3.1 Other developments
  • 12.1.9 ICAR-NIVEDI (NATIONAL INSTITUTE OF VETERINARY EPIDEMIOLOGY AND DISEASE INFORMATICS)
    • 12.1.9.1 Business overview
    • 12.1.9.2 Services offered
  • 12.1.10 NATIONAL VETERINARY SERVICES
    • 12.1.10.1 Business overview
    • 12.1.10.2 Services offered
    • 12.1.10.3 Recent developments
      • 12.1.10.3.1 Expansions
      • 12.1.10.3.2 Other developments
  • 12.1.11 TEXAS A&M VETERINARY MEDICAL DIAGNOSTIC LABORATORY (TVMDL)
    • 12.1.11.1 Business overview
    • 12.1.11.2 Services offered
    • 12.1.11.3 Recent developments
      • 12.1.11.3.1 Service launches and enhancements
  • 12.1.12 ANIMAL HEALTH DIAGNOSTIC CENTER, CORNELL UNIVERSITY
    • 12.1.12.1 Business overview
    • 12.1.12.2 Services offered
    • 12.1.12.3 Recent developments
      • 12.1.12.3.1 Service launches
      • 12.1.12.3.2 Expansions
  • 12.1.13 COLORADO STATE UNIVERSITY (VETERINARY DIAGNOSTIC LABORATORY)
    • 12.1.13.1 Business overview
    • 12.1.13.2 Services offered
  • 12.1.14 BIOBEST LABORATORIES LTD.
    • 12.1.14.1 Business overview
    • 12.1.14.2 Services offered
    • 12.1.14.3 Recent developments
      • 12.1.14.3.1 Expansions
  • 12.1.15 PRIVATE VETERINARY CLINIC SAN MARCO SRL UNIPERSONALE
    • 12.1.15.1 Business overview
    • 12.1.15.2 Services offered
• 12.2 OTHER PLAYERS
  • 12.2.1 ROYAL VETERINARY COLLEGE, UNIVERSITY OF LONDON
  • 12.2.2 UNIVERSITY OF GUELPH, ANIMAL HEALTH LABORATORY
  • 12.2.3 VAXXINOVA
  • 12.2.4 MIRA VISTA LABS
  • 12.2.5 ELLIE DIAGNOSTICS
  • 12.2.6 PROTATEK INTERNATIONAL, INC.
  • 12.2.7 THE PIRBRIGHT INSTITUTE
  • 12.2.8 CVR LABORATORY (CVRL)
  • 12.2.9 VETERINARY PATHOLOGY GROUP
  • 12.2.10 FRIEDRICH-LOEFFLER-INSTITUT (FLI)

13 APPENDIX

• 13.1 DISCUSSION GUIDE
• 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 13.3 CUSTOMIZATION OPTIONS
  • 13.3.1 SERVICE ANALYSIS
  • 13.3.2 COMPANY INFORMATION
  • 13.3.3 GEOGRAPHIC ANALYSIS
  • 13.3.4 REGIONAL/COUNTRY-LEVEL MARKET SHARE ANALYSIS
  • 13.3.5 COUNTRY-LEVEL VOLUME ANALYSIS BY PRODUCT
  • 13.3.6 BY SERVICE MARKET SHARE ANALYSIS (TOP 5 PLAYERS)
  • 13.3.7 ANY CONSULT/CUSTOM REQUIREMENTS AS PER CLIENT REQUESTS
• 13.4 RELATED REPORTS
• 13.5 AUTHOR DETAILS